Clinical Trials Browser

Interventional × Leukemia, Large Granular Lymphocytic × Thalidomide × Clear all

NCT06530576 2025-11-18

Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Large Granular Lymphocytic

NCT04453345 2020-07-01

TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL

Phase 2/3 Unknown

Other hematologic neoplasm

Leukemia, Large Granular Lymphocytic